Greg Rossi

Greg Rossi is a seasoned executive in the oncology field, currently serving as Senior Vice President for Oncology Europe and Canada at AstraZeneca since September 2011. Rossi has held multiple key leadership positions within AstraZeneca, including Vice President roles overseeing global franchise management for Lynparza and other oncology medicines, as well as responsibilities in health economics, pricing, and market access across all therapy areas. Prior to joining AstraZeneca, Rossi held significant roles at Roche Pharmaceuticals and Genentech, specializing in health economics and pricing strategies. Rossi began a career in oncology at Amgen, where various leadership positions, including Executive Director of Global Marketing and Global Development Leader, were held. Rossi earned a Ph.D. in Molecular Biology/Protein Chemistry from UCL between 1989 and 1994.